Behind the Mystery: Diagnosing Endogenous Cushing Syndrome
July 20, 2016
Strongbridge Biopharma: Driven by Passion. Focused on Results.
On today’s special series “Behind the Mystery,” we’re talking about Cushing syndrome, a rare hormonal disorder that is too often misdiagnosed where patients are simply told to lose weight! An estimated 25,000 patients in the United States and 40,000 patients in Europe are currently diagnosed with endogenous Cushing syndrome. Endogenous Cushing syndrome is believed to be underdiagnosed due to lack of disease recognition by the treating physician, which often leads to a delay in diagnosis on average of six years. Host Olga Villaverde will talk with Dr. Maria Fleseriu and patient Leslie Edwin, to raise awareness about Cushing syndrome and discuss symptoms and ways to properly diagnosis it.
Fall is in the air, which means football, family gatherings, and good times! Chef Ralph Pagano returns with a new edition of Quick Bytes with Dole Foods.
Broadway Across America is back! Go on an epic adventure as host Amber Milt takes us inside the romantic new musical Anastasia.
Salveo Diagnostics uses state-of-the-art laboratory testing, which puts emphasis on a patient's gut health, to identify chronic disease.